


This lung cancer panel is a high throughput next-generation sequencing based single assay that may provide treatment benefit to the patients. This next-generation sequencing based multi-gene lung cancer test is developed to sequence and identify genomic alterations associated with genes having therapeutic, prognostic and diagnostic implications.